Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 6/20 | 1.00 |
| ▸ | NR4A2 | P43354 | 2/20 | 1.00 |
| ▸ | SSTR5 | P35346 | 8/20 | 0.73 |
| ▸ | HRH1 | P35367 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 2/20 | 0.61 |
| ▸ | GAA | P10253 | 2/20 | 0.61 |
| ▸ | HTR3A | P46098 | 2/20 | 0.61 |
| ▸ | EED | O75530 | 2/20 | 0.61 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.61 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | MLNR | O43193 | 1/20 | 0.61 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.61 |
| ▸ | HLA-A | P04439 | 1/20 | 0.61 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tecastemizole SCHEMBL9698437 | 0.99 | KCNH2 (0.98) | KCNH2NR4A2SSTR5HRH1LMNA | |
| Tecastemizole SCHEMBL11278980 | 0.99 | KCNH2 (0.98) | KCNH2NR4A2SSTR5HRH1LMNA | |
| Tecastemizole SCHEMBL1652801 | 0.98 | KCNH2 (0.96) | KCNH2NR4A2SSTR5HRH1LMNA | |
| Tecastemizole SCHEMBL10510276 | 0.96 | KCNH2 (0.92) | KCNH2NR4A2SSTR5HRH1LMNA | |
| Hydrochloric Acid SCHEMBL9631298 | 0.95 | KCNH2 (0.90) | KCNH2NR4A2SSTR5HRH1LMNA | |
| SCHEMBL9629886 | 0.93 | KCNH2 (0.88) | KCNH2NR4A2SSTR5HRH1LMNA | |
| SCHEMBL9698374 | 0.91 | KCNH2 (0.83) | KCNH2NR4A2SSTR5HRH1LMNA | |
| SCHEMBL11265895 | 0.91 | KCNH2 (0.83) | KCNH2NR4A2SSTR5HRH1LMNA | |
| Bromide SCHEMBL11305424 | 0.90 | KCNH2 (0.81) | KCNH2NR4A2SSTR5HRH1LMNA | |
| Alcohol SCHEMBL10518396 | 0.89 | KCNH2 (0.79) | KCNH2NR4A2SSTR5HRH1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2864 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12569451-B2 | Bio-inspired tissue-adhesive hydrogel patch and uses thereof | Cellartgen Inc. (KR) | 2026-03-10 | — | — | US | claimed |
| EP-4691568-A2 | LOW-DOSE BRIMONIDINE COMBINATIONS AND USES THEREOF | Eye Therapies, LLC (US) | 2026-02-11 | — | — | EP | claimed |
| EP-4565206-A1 | OPHTHALMIC COMPOSITION COMPRISING PILOCARPINE AND A REDNESS REDUCTION AGENT | Bausch + Lomb Ireland Limited (IE) | 2025-06-11 | — | — | EP | claimed |
| WO-2025111482-A1 | COMPLEXING AGENT SALT FORMULATIONS OF PHARMACEUTICAL COMPOUNDS AT LOW STOICHIOMETRIC RATIOS | BEXSON BIOMEDICAL, INC. (US) | 2025-05-30 | — | — | WO | claimed |
| EP-3508501-B1 | USE OF ANTI-CGRP ANTIBODIES AND ANTIBODY FRAGMENTS TO PREVENT OR INHIBIT PHOTOPHOBIA OR LIGHT AVERSION IN SUBJECTS IN NEED THEREOF, ESPECIALLY MIGRAINE SUFFERERS | H LUNDBECK AS (DK) | 2024-11-06 | — | — | EP | claimed |
| WO-2024028816-A1 | OPHTHALMIC COMPOSITION COMPRISING PILOCARPINE AND A REDNESS REDUCTION AGENT | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-02-08 | — | — | WO | claimed |
| WO-2024028815-A1 | OPHTHALMIC COMPOSITION COMPRISING AN ANTI-ALLERGEN AND A REDNESS REDUCTION AGENT | BAUSCH + LOMB IRELAND LIMITED (IE) | 2024-02-08 | — | — | WO | claimed |
| US-20230287510-A1 | COMPOSITIONS, PANELS, AND METHODS FOR CHARACTERIZING CHRONIC LYMPHOCYTIC LEUKEMIA | THE BROAD INSTITUTE, INC. (US) | 2023-09-14 | — | — | US | claimed |
| EP-4178534-A1 | OPHTHALMIC FORMULATION AND METHODS OF USE | Alqallawi, Abdelhamid Muhammad (EG) | 2023-05-17 | — | — | EP | claimed |
| US-20220280442-A1 | BIO-INSPIRED TISSUE-ADHESIVE HYDROGEL PATCH AND USES THEREOF | Cellartgen Inc. (KR) | 2022-09-08 | — | — | US | claimed |
| WO-1999052555-A1 | METHODS AND COMPOSITIONS USING NORASTEMIZOLE IN COMBINATION WITH LEUKOTRIENE INHIBITORS | SEPRACOR INC. (US) | 1999-10-21 | — | — | WO | claimed |
| WO-1999032125-A1 | COMPOSITION FOR TREATING RESPIRATORY AND SKIN DISEASES, COMPRISING AT LEAST ONE LEUKOTRIENE ANTAGONIST AND AT LEAST ONE ANTIHISTAMINE | SCHERING CORPORATION (US) | 1999-07-01 | — | — | WO | claimed |
| EP-0920315-A1 | TREATMENT OF UPPER AIRWAY ALLERGIC RESPONSES WITH A COMBINATION OF HISTAMINE RECEPTOR ANTAGONISTS | SCHERING CORPORATION (US) | 1999-06-09 | — | — | EP | claimed |
| WO-1999025328-A1 | (+)-EPHEDRINE AS A SYMPATHOMIMETIC DRUG | WARNER-LAMBERT COMPANY (US) | 1999-05-27 | — | — | WO | claimed |
| US-5869479-A | ADMINISTERING HISTAMINE H1 RECEPTOR ANTAGONISTS AND HISTAMINE H3 RECEPTOR ANTAGONISTS; NASAL DECONGESTANT WITHOUT THE NERVOUS SYSTEM OR CARDIOVASCULAR SIDE EFFECTS | SCHERING CORPORATION (US) | 1999-02-09 | — | — | US | claimed |
| WO-1998048839-A1 | TOPICAL NASAL ANTIINFLAMMATORY COMPOSITIONS | WARNER-LAMBERT COMPANY (US) | 1998-11-05 | — | — | WO | claimed |
| WO-1998046571-A1 | METHODS FOR SYNTHESIZING 2-SUBSTITUTED IMIDAZOLES | SEPRACOR INC. (US) | 1998-10-22 | — | — | WO | claimed |
| US-5817823-A | ALKYLATION OF AN IMIDAZOLE COMPOUND; COUPLING WITH NUCLEOPHILIC COMPOUND | SEPRACOR INC. (US) | 1998-10-06 | — | — | US | claimed |
| WO-1998042379-A2 | CHEMICALLY AND THERMALLY STABLE NORASTEMIZOLE FORMULATIONS | SEPRACOR INC. (US) | 1998-10-01 | — | — | WO | claimed |
| WO-1998006394-A1 | TREATMENT OF UPPER AIRWAY ALLERGIC RESPONSES WITH A COMBINATION OF HISTAMINE RECEPTOR ANTAGONISTS | SCHERING CORPORATION (US) | 1998-02-19 | — | — | WO | claimed |